Crossject SA
PAR:ALCJ

Watchlist Manager
Crossject SA Logo
Crossject SA
PAR:ALCJ
Watchlist
Price: 2.155 EUR 3.11% Market Closed
Market Cap: €113.9m

Relative Value

The Relative Value of one ALCJ stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.155 EUR, Crossject SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALCJ Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ALCJ Competitors Multiples
Crossject SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Crossject SA
PAR:ALCJ
109.2m EUR 0 -9.5 -21.5 -9.9
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38 27.5 33
US
Medline Inc
NASDAQ:MDLN
55.5B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
29.4B CHF 3.6 38.5 14.8 28.8
DK
Coloplast A/S
CSE:COLO B
100.6B DKK 3.6 25.4 13.3 15.9
US
Align Technology Inc
NASDAQ:ALGN
12.3B USD 3.1 30 12.9 17.7
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.5 34.6 12 18.8
CA
Bausch + Lomb Corp
NYSE:BLCO
5.7B USD 1.1 -15.7 16.9 54.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
39.8B CNY 8.7 24.1 21.7 21.7
CN
Intco Medical Technology Co Ltd
SZSE:300677
40.1B CNY 4.1 23.4 35.1 35.1
JP
Asahi Intecc Co Ltd
TSE:7747
828.9B JPY 6.4 46.9 22.1 30
P/E Multiple
Earnings Growth PEG
FR
Crossject SA
PAR:ALCJ
Average P/E: 32.6
Negative Multiple: -9.5
N/A N/A
JP
Hoya Corp
TSE:7741
38
14%
2.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available
29%
N/A
CH
Alcon AG
SIX:ALC
38.5
32%
1.2
DK
Coloplast A/S
CSE:COLO B
25.4
21%
1.2
US
Align Technology Inc
NASDAQ:ALGN
30
34%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
34.6
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.7 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
9%
2.7
CN
Intco Medical Technology Co Ltd
SZSE:300677
23.4
12%
2
JP
A
Asahi Intecc Co Ltd
TSE:7747
46.9
38%
1.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Crossject SA
PAR:ALCJ
Average EV/EBITDA: 19.6
Negative Multiple: -21.5
N/A N/A
JP
Hoya Corp
TSE:7741
27.5
12%
2.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
9%
N/A
CH
Alcon AG
SIX:ALC
14.8
9%
1.6
DK
Coloplast A/S
CSE:COLO B
13.3
6%
2.2
US
Align Technology Inc
NASDAQ:ALGN
12.9
14%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
12
11%
1.1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.9
29%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.7
13%
1.7
CN
Intco Medical Technology Co Ltd
SZSE:300677
35.1
51%
0.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
22.1
12%
1.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Crossject SA
PAR:ALCJ
Average EV/EBIT: 28.4
Negative Multiple: -9.9
N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
28.8
27%
1.1
DK
Coloplast A/S
CSE:COLO B
15.9
7%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.7
21%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
18.8
23%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
54.8
74%
0.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
21.7
11%
2
CN
Intco Medical Technology Co Ltd
SZSE:300677
35.1
24%
1.5
JP
A
Asahi Intecc Co Ltd
TSE:7747
30
N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett